MedMira HIV Test

 

MedMira Rapid HIV Test is designed to detect antibodies to HIV-1 and HIV-2, and can be used in a wide range of testing environments from clinical laboratories to mobile testing clinics in developing countries to point-of-care testing in hospitals.

The MedMira Rapid HIV Test is approved for sale in the People’s Republic of China by the State Food and Drug Administration. It is the first whole blood rapid HIV test approved for sale in P.R. China.

MedMira Rapid HIV Test Laboratory format uses whole blood, serum or plasma specimens and is volume packaged for large scale research and public health testing programs.

MedMira Rapid HIV Test Point-of-Care format is sold in packages of single test kits with all the necessary components inside one pouch. This format uses whole blood, serum or plasma specimens and is ideal for doctors’ offices, mobile testing clinics, resource limited settings and hospitals that require smaller numbers of tests be available in various departments for point-of-care testing.

Distributed by:

Triplex International Biosciences Co., Ltd.
4/F., Tower 7, No7 Jinzhou North Rd.
Jinshan, Fuzhou, Fujian, China
T: 86-591-28053600
E: tib@tibchina.com
W: www.tibchina.com

 

Learn More About MedMira Rapid HIV Test

MedMira Rapid HIV Test (Whole Blood) Package Insert
(中文/EN)

MedMira Rapid HIV Test (Serum/Plasma) Package Insert
(中文/EN)

China Food and Drug Administration (CFDA) Certificate

MedMira Rapid HIV Test Brochure
(中文)